DERIVES PYRROLO[2,1-F] [1,2,4] TRIAZIN-4-YLAMINES COMME INHIBITEURS DE LA IGF-1R KINASE POUR LE TRAITEMENT DES CANCERS ET D'AUTRES MALADIES HYPERPROLIFERATIVES
This invention relates to novel compounds of formula (I). Formula (I) in which the variable groups are as defined in the specification and claims, to pharmaceutical compositions containing them, and to a method of treatment using them for treatment of cancer.